论文部分内容阅读
目的:考察血液灌流联合血液透析(HP+HD)治疗尿毒症合并难治性高血压患者的临床疗效。方法:选择尿毒症合并顽固性高血压患者60例,随机分为两组(各30例),研究组采用血液灌流联合血液透析进行治疗,对照组采用单纯血液透析进行治疗,并比较两组患者治疗情况。结果:研究组血压明显有所下降,和对照组对比差异具有统计学意义(P<0.05)。结论:血液灌流联合血液透析在治疗尿毒症合并难治性高血压方面疗效明显,值得临床推广应用。
Objective: To investigate the clinical efficacy of hemoperfusion combined with hemodialysis (HP + HD) in the treatment of patients with uremia complicated with refractory hypertension. Methods: 60 uremic patients with refractory hypertension were randomly divided into two groups (30 in each). The study group was treated with hemoperfusion combined with hemodialysis. The control group was treated with hemodialysis alone. The patients in two groups were compared Treatment situation. Results: The study group had a significant decrease in blood pressure, which was significantly different from the control group (P <0.05). Conclusion: Hemoperfusion combined with hemodialysis in the treatment of uremia with refractory hypertension obvious curative effect, it is worthy of clinical application.